Allen Seftel, MD
Urology · Camden, NJNPI 1538187653
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.5% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Boston Scientific at 34.6% of the total. That places this record below the midpoint for urology clinicians in NJ, where the typical reported total is $2,095.
Across 67 payments — averaging $35.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$822
- Dentsply IH AB$313
- Endo Pharmaceuticals Inc.$251
- Teleflex LLC$178
- Neotract Inc.$164
- Davol Inc.$145
- plus $500 from 10 others
Across 18 payments — averaging $1211.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$21K
- Steris Instrument Management Services, Inc.$1K
What the payments were for
- Food & beverage$2,29096%
- Education$834%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 13 | $822 |
| Dentsply IH AB | 9 | $313 |
| Endo Pharmaceuticals Inc. | 15 | $251 |
| Teleflex LLC | 3 | $178 |
| Neotract Inc. | 5 | $164 |
| Davol Inc. | 2 | $145 |
| Medtronic(2 entities) | 2 | $138 |
| 180 Medical, Inc. | 3 | $72 |
| Astellas Pharma US Inc | 4 | $58 |
| Coloplast | 4 | $57 |
| Laborie Medical Technologies Corp. | 1 | $41 |
| Convatec Inc. | 1 | $39 |
| Dendreon Pharmaceuticals LLC | 2 | $33 |
| Civco Medical Instruments | 1 | $27 |
| Axonics, Inc. | 1 | $24 |
| AbbVie | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LithoVue$295
- UroLift$249
- GENERAL ERECTILE DYSFUNCTION$119
- AMS$112
- ARISTA AH FLEXITIP$106
How this compares
$2,373 in reported general payments places this provider in the 50th percentile of 401 urology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiaflexCollagenase Clostridium Hist. | 20 | $267,063 |
| MyrbetriqMirabegron | 78 | $49,778 |
| Tamsulosin Hcl | 612 | $11,577 |
| Tadalafil | 85 | $4,463 |
| Testosterone | 21 | $4,106 |
| Finasteride | 198 | $3,527 |
| CialisTadalafil | 12 | $3,043 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 93 | $2,317 |
| Testosterone Cypionate | 37 | $1,825 |
| Solifenacin Succinate | 59 | $1,800 |
| Silodosin | 19 | $1,733 |
| Terazosin Hcl | 52 | $884 |
| Dutasteride | 19 | $820 |
| Trospium Chloride | 20 | $793 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 42 | $595 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Endo Pharmaceuticals Inc.Xiaflex | $251 | $267,06320 claims |
| Astellas Pharma US IncMyrbetriq | $58 | $49,77878 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 401 urology providers in New Jersey.
Other urology in Camden
- Timothy AverchCamden$30K
- Michael StifelmanHackensack$1.4M
- Gordon BrownCherry Hill$1.3M
- Thomas MuellerLinwood$1.1M
- David SussmanLinwood$802K
- Michael IngberDenville$530K
- Ravi MunverHackensack$529K
- Grannum SantBridgewater$487K
- Mutahar AhmedMaywood$414K
- Kevin GioiaRumson$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.